Oxford Biomedical Research

Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins, and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. The company recently introduced CypExpress, individual human P450’s expressed in yeast, for the rapid identification and production of P450 metabolites. The company also offers a complete line of human and rat GST enzymes and matching antibodies validated for IHC.

Major product lines

  • Eicosanoids
  • Drug metabolism
  • Oxidative stress
  • Vascular biology
  • Signal transduction

Oxford Biomedical Research news

For more information, please visit: www.oxfordbiomed.com